FDA grants speedy approval to Eli Lilly weight-loss pill
Quick Insights
The Bottom Line
FDA approved Eli Lilly's once-daily weight-loss pill Foundayo, offering a pill alternative to weekly injection GLP-1 drugs.
How This Affects You
Patients seeking weight-loss treatment now have an oral pill option instead of injections, though insurance coverage and out-of-pocket costs will depend on individual plans.
AI Summary
The FDA approved Eli Lilly's once-daily weight-loss pill orforglipron, branded as Foundayo, with the company set to begin shipping the drug as soon as Monday. The approval adds another GLP-1 medication to an increasingly crowded market of weight-loss drugs that have become blockbuster treatments over the past two years. The once-daily oral format differentiates Foundayo from existing GLP-1 options like semaglutide and tirzepatide, which typically require weekly injections or daily injections, potentially appealing to patients who prefer pills over shots. The drug's entry into the market intensifies competition among major pharmaceutical manufacturers vying for share of the lucrative weight-loss medication sector. Eli Lilly, which also manufactures Mounjaro and Zepbound, expands its foothold in the GLP-1 space with a product designed to capture patients seeking an oral alternative.
What's Being Done
The FDA granted approval and Eli Lilly is beginning shipments.
Source Coverage Map
6 of 43 tracked sources covered this story
Following this story?
Get notified when new coverage appears
Other Sources Covering This Story
5 sourcesMultiple outlets have reported on this story. Compare perspectives from different sources.
This article is part of a story we're tracking:
Should this be getting more attention?
You Might Have Missed
Related stories from different sources and perspectives
HealthFDA grants speedy approval to Eli Lilly's weight-loss pill for obesity
The Food and Drug Administration's decision Wednesday means patients in the United States will soon have access to a second daily oral medication to treat obesity and weight-related issues.
HealthUS approves new oral weight-loss pill developed by Eli Lilly
<p>Called Foundayo, the tablet becomes the second one to receive FDA’s green light after Novo Nordisk’s Wegovy</p><p>The US Food and Drug Administration (FDA) gave the green light on Wednesday to a new oral weight-loss medication developed by the Indianapolis-based pharmaceutical company Eli Lilly.</p><p>Known as orforglipron or brand name Foundayo, the once-daily tablet becomes the second GLP-1 drug in pill form to hit the market in a short span of time, arriving after Novo Nordisk’s Wegovy pill received <a href="https://www.theguardian.com/us-news/2025/dec/22/us-regulators-approve-wegovy-weight-loss-pill">approval</a> in December.</p> <a href="https://www.theguardian.com/us-news/2026/apr/01/new-weight-loss-pill-glp-1-foundayo">Continue reading...</a>
CorporateInsilico Medicine secures $2.75 billion drug collaboration with Eli Lilly - Reuters
<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxQRUtWbXlUNS04X1dualdiUTg0ME11ajdLb3FGekwyT1lXbFhmT2ltNUVUUVFna1RQYmh6OUJRcWd5bk1ETXE0LUNWbVRRU0NQUFFYaWk4bXlwX3EwX1lSTW1WWHFsV2c3R0ZpT1p6S29fMDlBdzhtRy1VY1VoV1hDaGg3UnJzNDlkSGVTeE5HckNCUmxBNUZxN3dhRm1FT2ltaE43UDVQUUMtQTZIdkRPV1dreGVXOEljMEdoVlNZXzd4Z2N3RXdUWkFZdnVtUEFpRHlXaWtMZ092ajV6MDNr?oc=5" target="_blank">Insilico Medicine secures $2.75 billion drug collaboration with Eli Lilly</a> <font color="#6f6f6f">Reuters</font>
PoliticsTrump approval slips to 33 percent in new survey
President Trump’s approval rating dipped to a new low, and even fewer people surveyed in a new poll said they support his administration’s war efforts against Iran. In a University of Massachusetts Amherst poll released Monday, 33 percent of respondents said they approve of the president’s job performance. Of the 62 percent who said they…
HealthNew heart health dietary guidelines
The American Heart Association has released new dietary guidelines on how to stay heart healthy to improve quality of life and save lives. Dr. Celine Gounder breaks down what to know.
HealthCeline Dion announces first concerts since stiff-person syndrome diagnosis with Paris residency - AP News
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxNTmZ3RmpKanhzZzhhRXBvbzFHdjF0SnItcWM3Y0d1aHhhd2xfZG0wVmZieC1fZ3VlZXRucGpFakhvcGVETUtfQXczOFZOMlBPOXhNcnhVSXYxdGh6QjNyRlNfRFBsbUJKY21OVzl0T3dqR09idE1KWmRld0JudlQ1Ti1FX0VXR0pLY3g0ZVlrRkQ?oc=5" target="_blank">Celine Dion announces first concerts since stiff-person syndrome diagnosis with Paris residency</a> <font color="#6f6f6f">AP News</font>
CDC temporarily halts testing for several infectious diseases amid staffing shortages
<p>Federal agency, which normally supports state and local public health labs, has been hobbled by staff departures</p><ul><li><p><a href="https://www.theguardian.com/news/2026/feb/17/sign-up-for-the-breaking-news-us-email-to-get-newsletter-alerts-direct-to-your-inbox?utm_medium=ACQUISITIONS_STANDFIRST&utm_campaign=BN22326&utm_content=signup&utm_term=standfirst&utm_source=GUARDIAN_WEB">Sign up for the Breaking News US email to get newsletter alerts in your inbox</a></p></li></ul><p>The US federal agency responsible for monitoring diseases has temporarily halted certain diagnostic testing, including those for rabies, human herpesvirus and several other <a href="https://www.theguardian.com/science/infectiousdiseases">infectious illnesses</a>.</p><p>The Centers for Disease Control and Prevention (CDC) released <a href="https://cdc.gov/infectious-diseases-labs/php/test-directory/index.html">a list</a> on Monday showing that more than two dozen types of testing are now un...
Did this story change how you see things?
Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.
The Verity Ledger curates verified investigative journalism from trusted sources only.
See our sourcesMost Read This Week
After 16 years and $8 billion, the military's new GPS software still doesn't work
US paves way for private assets to be included in 401(k) retirement plans - Reuters
Trump administration scales back on asylum crackdown, sources say
European nations warn over Israel’s planned expansion of death penalty
WTO talks near deal on reform roadmap amid US-India e-commerce deadlock - Reuters
